B. Hermans, R. Materne, J. Marot
Apr 4, 2000
Citations
0
Influential Citations
4
Citations
Quality indicators
Journal
European Urology
Abstract
Indinavir sulfate is a protease inhibitor of the human immunodeficiency virus (HIV) type 1, that is widely used to treat patients with HIV infection. Indinavir therapy is associated with a significant incidence of crystalluria and urolithiasis [1]. These calculi are not opaque and consist of monohydrate indinavir crystals. Computed tomographic findings of ureteral calculi in patients with HIV receiving indinavir sulfate have recently been reported [2, 3]. Diagnosis is difficult with unenhanced computed tomography, and images after intravenous injection of an iodinated contrast agent may need to be performed to identify the cause of obstruction. We report a case of bilateral ureteral calculi demonstrated by magnetic resonance (MR) urography in an HIV-infected patient treated with indinavir sulfate.